Journal of Gastrointestinal Infections

Register      Login

VOLUME 5 , ISSUE 1 ( 2015 ) > List of Articles

CASE REPORT

Ileo-cecal mucormycosis in an immune competent adult: Treating successfully a rare disease with high mortality

P.K. Thatoi, S. Khadanga, Ujjawal Khurana, D. Dugar, S. P. Satapathy, T Karuna

Keywords : Gastrointestinal mucormycosis, Ileo-cecal, Immunocompetent

Citation Information : Thatoi P, Khadanga S, Khurana U, Dugar D, Satapathy SP, Karuna T. Ileo-cecal mucormycosis in an immune competent adult: Treating successfully a rare disease with high mortality. J Gastrointest Infect 2015; 5 (1):50-53.

DOI: 10.5005/jp-jogi-5-1-50

License: CC BY-SA 4.0

Published Online: 01-12-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Mucormycosis is common in immunocompromised patients. Among the various clinical spectrum of mucormycosis gastrointestinal mucormycosis has been documented in about seven percent of cases, more commonly in pediatric population. In large studies (mostly in immunocompromised) the mortality has been documented even up to 100%. Only nine cases have been described so far in immune competent adults globally including ours. We present here a case of successful treatment of ileo-cecal mucormycosis in an immunocompetent middle age man from eastern part of India. This case will enlighten the clinicians and broaden their vision of differential diagnosis while dealing with cases of non- specific pain abdomen. This case also highlights the importance of microbiological studies in addition to conventional biopsy and histopathology alone.


PDF Share
  1. Brown OE, Finn R. Mucormycosis of the mandible. J Oral Maxillofac Surg. 1986;44:132-6.
  2. Rapidis AD. Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon. Clin Microbiol Infect. 2009;15:98-102.
  3. Gamaletsou MN, Sipsas NV, Roilides E, Walsh TJ. Rhino-orbitalcerebral mucormycosis. Curr Infect Dis Resp. 2012;14:423-34.
  4. Roden M, Zaoutis T, Buchanan W, Knudsen T, Sarkisova T, Schaufele R, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2005;41:634-53.
  5. Zaoutis T, Roilides E, Chiou C, Buchanan W, Knudsen T, Sarkisova T, et al. Zygomycosis in children: a systematic review and analysis of reported cases. The Pediatric Infectious Disease Journal. 2007;26:723-27.
  6. Shiva Prasad BN, Shenoy A, Nataraj KS. Primary gastrointestinal mucormycosis in an immunocompetent person. J Postgrad Med. 2008;54:211-3.
  7. Carr EJ, Scott P, Gradon JD. Fatal gastrointestinal mucormycosis that invaded the postoperative abdominal wall wound in an immunocompetent host. Clin Infect Dis. 1999;29:956-7.
  8. Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG, Manrique-Larralde A, Torroba L, Urtasun J, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med. 2004;30:724-8.
  9. Nitin Chawla, S. Jayabhaskar Reddy, Mukesh Agrawal. Ileocolic mucormycosis causing intestinal obstruction. Infect Dis Clin North Am. 2006;20:581-607.
  10. Martinello M, Nelson A, Bignold L, Shaw D. We are what we eat! Invasive intestinal mucormycosis: A case report and review of the literature. Med Mycol Case Rep. 2012;1:52-5.
  11. Smith JL, Stevens DA. Survival in cerebro-rhino-orbital zygomycosis and cavernous sinus thrombosis with combined therapy. South Med J. 1986;79:501-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.